Rhinoviruses significantly affect day-to-day respiratory symptoms of children with asthma

J Allergy Clin Immunol. 2015 Mar;135(3):663-9.e12. doi: 10.1016/j.jaci.2014.10.020. Epub 2014 Dec 2.

Abstract

Background: Viruses are frequently associated with acute exacerbations of asthma, but the extent to which they contribute to the level of day-to-day symptom control is less clear.

Objective: We sought to explore the relationship between viral infections, host and environmental factors, and respiratory symptoms in children.

Methods: Sixty-seven asthmatic children collected samples twice weekly for an average of 10 weeks. These included nasal wash fluid and exhaled breath for PCR-based detection of viral RNA, lung function measurements, and records of medication use and asthma and respiratory symptoms in the previous 3 days. Atopy, mite allergen exposure, and vitamin D levels were also measured. Mixed-model regression analyses were performed.

Results: Human rhinoviruses (hRVs) were detected in 25.5% of 1232 nasal samples and 11.5% of breath samples. Non-hRV viruses were detected in less than 3% of samples. hRV in nasal samples was associated with asthma symptoms (cough and phlegm: odds ratio = 2.0; 95% CI = 1.4-2.86, P = .0001; wheeze and chest tightness: odds ratio = 2.34, 95% CI = 1.55-3.52, P < .0001) and with cold symptoms, as reported concurrently with sampling and 3 to 4 days later. No differences were found between the 3 hRV genotypes (hRV-A, hRV-B, and hRV-C) in symptom risk. A history of inhaled corticosteroid use, but not atopic status, mite allergen exposure, or vitamin D levels, modified the association between viruses and asthma symptoms.

Conclusion: The detection of nasal hRV was associated with a significantly increased risk of day-to-day asthma symptoms in children. Host, virus genotype, and environmental factors each had only a small or no effect on the relationship of viral infections to asthma symptoms.

Keywords: Virus; asthma; asthma control; children; mixed-model analysis; respiratory; rhinovirus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Anti-Asthmatic Agents / therapeutic use
  • Antigens, Dermatophagoides / blood
  • Antigens, Dermatophagoides / immunology
  • Asthma / complications*
  • Asthma / drug therapy
  • Asthma / immunology
  • Asthma / physiopathology
  • Child
  • Child, Preschool
  • Cough / physiopathology
  • Female
  • Genotype
  • Humans
  • Male
  • Picornaviridae Infections / complications*
  • Picornaviridae Infections / drug therapy
  • Picornaviridae Infections / immunology
  • Picornaviridae Infections / physiopathology
  • Regression Analysis
  • Respiratory Function Tests
  • Respiratory Sounds / physiopathology
  • Rhinovirus / genetics
  • Rhinovirus / immunology*
  • Vitamin D / blood
  • Vitamin D / immunology

Substances

  • Adrenal Cortex Hormones
  • Anti-Asthmatic Agents
  • Antigens, Dermatophagoides
  • Vitamin D